Wayne Fenton, M.D. Award for Exceptional Clinical Care
The Schizophrenia Bulletin is pleased to announce the establishment of a Wayne Fenton, M.D. Award for Exceptional Clinical Care. This program is designed to recognize providers (individuals and groups) who exemplify Dr. Fenton's commitment to improving the daily lives of individuals with schizophrenia. As CEO of the Chestnut Lodge Hospital and later as Director of the Division of Adult Translational Research at NIMH, Dr. Fenton worked tirelessly to ensure that clients were afforded the best possible treatment. He used his position to make the scientific community aware of the need for improvements in the mental health system, but also made himself available to patients in their times of greatest need.
The award will consist of a $1000 cash prize and a five-year complimentary subscription to Schizophrenia Bulletin. Candidacy is open to any credentialed individual (alive or recently deceased) or professional group engaged in the care and treatment of individuals with schizophrenia. Nominations will be accepted from professional colleague(s) or from organizations such as mental health advocacy and consumer groups. Applications must include:
- A completed nomination form. Multiple forms should be used if more than one individual is nominating a candidate.
- • A brief essay (500-2000 words) describing how the actions of the individual or group embody the traits displayed by Dr. Fenton in his professional career, specifically ways in which the nominee has improved treatment outcome or patient welfare through demonstrable compassion, dedication, and advocacy in the field of schizophrenia research and treatment. Nominators are strongly encouraged to cite specific instances and actions that support the general narrative, including documents such as media reports, professional citations, and feedback from patients and their families. Please avoid the use of technical jargon or excessive use of abbreviation. Nomination essays should be appropriate for publication and contain no information of a confidential nature.
- A signed cover letter from the nominator(s) or individual representing the nominating organization stating that the narrative portion of the application is an accurate representation of the nominee in question.
Nominations should be sent via email no later than May 1, 2014 to:
Nominators should attach the nomination form, brief essay and cover letter to the email.
All nominations received by the deadline will be reviewed by a panel of judges who will evaluate each candidate on the basis of outstanding contributions in the delivery of clinical care. The winner of the award will be announced in the September 2012 issue of Schizophrenia Bulletin, published alongside the recipient’s nomination narrative.
To download a copy of the nomination form, please click here.
Published in association with
Impact factor: 8.486
5-Yr impact factor: 8.934
Open access options for authors - visit Oxford Open